Sangamo Therapeutics
SGMO
#10513
Rank
HK$0.16 B
Marketcap
HK$0.39
Share price
0.00%
Change (1 day)
-90.75%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total debt

Total debt on the balance sheet as of September 2025 : HK$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total debt is HK$0.19 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sangamo Therapeutics - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$0.23 B-20.26%
2023-12-31HK$0.29 B-11.64%
2022-12-31HK$0.33 B-10.16%
2021-12-31HK$0.37 B14.91%
2020-12-31HK$0.32 B-5.66%
2019-12-31HK$0.34 B59.5%
2018-12-31HK$0.21 B12.19%
2017-12-31HK$0.19 B531.79%
2016-12-31HK$30.59 M
2015-12-31N/A
2001-12-31HK$2.22 M
1999-12-31HK$2.33 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.22 B 216,179.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$449.54 B 225,368.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$51.46 B 25,709.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
HK$153.93 B 77,106.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$173.89 B 87,116.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$385.19 B 193,091.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$9.98 B 4,907.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$11.28 B 5,562.37%๐Ÿ‡บ๐Ÿ‡ธ USA